This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.62% per year. These returns cover a period from January 1, 1988 through June 2, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Wild Stock Market Ride Continues, Plus Feb. CPI
by Mark Vickery
Only when market participants truly have a good idea how far-reaching COVID-19 ultimately is will we begin to see light at the end of the tunnel.
Coronavirus: How Bad Will It Get?
by John Blank
As policy measures to contain the disease -- to prevent further illnesses and fatalities -- spread and deepen, it also becomes necessary. Investors must grapple with the degree to which this will affect business activity, both in the U.S. and around the globe.
Coronavirus Vs. 2008 Financial Crisis
by Daniel Laboe
The spread of the coronavirus is undoubtedly going to continue, but will this lead to an economic downturn?
Stormy Monday: Crude Oil, Coronavirus, Repo Drench Markets
by Mark Vickery
Oil markets fell 10% Friday, and on Sunday, Goldman Sachs (GS) said that global oil price war could send prices down to $20 per barrel.
The Reasons Behind The Coronavirus Crash
by Daniel Laboe
The coronavirus has caused widespread panic in the markets with all the major indexes are over 13% off their highs
5 Preferred Stock ETFs Yielding 5% or More & Losing Little
by Sanghamitra Saha
These preferred ETFs are yielding more than 5% annually and losing little in prices amid the market bloodbath.
Nonfarm Payrolls Reach Peak: 273K, 3.5% Unemployment
by Mark Vickery
In normal times, today's Employment Situation Report from the U.S. Bureau of Labor Statistics (BLS) of 273K new jobs created in the month of February would be cause for celebration, as would the Unemployment Rate coming down to 3.5%.
Coronavirus Market Flip-Flops Continue
by Mark Vickery
Still grappling with coronavirus data both in the U.S. and abroad remains the primary culprit in this morning's sell-off.
Most Actively Traded ETFs Over the Past 20 Days
by Sweta Killa
We have profiled 10 ETFs that have seen massive trading volumes over the past 20 days.
Market Roller Coaster Takes Dow Up 600+ Points
by Mark Vickery
Pre-markets are way up this morning, following a drop of around 3% in the major U.S. indexes yesterday. This followed Monday's single-highest-point trading day in Dow Jones history.
G7 Disappoints Traders Looking for Relief
by Mark Vickery
The finance ministers of the G7 said they "stand ready to fight the coronavirus downturn," but offered no concrete proposals.
Stimulus Hopes Triumph Over Virus: 5 Top ETF Picks for March
by Sanghamitra Saha
These top-ranked ETFs could prove profitable for investors in the month of March.
Top ETF Stories of Virus-Infected February
by Sanghamitra Saha
These ETF headlines are worth watching amid rising virus scare in February.
Correction Territory, but How Will Markets Correct?
by Mark Vickery
Forward guidance for companies across a wide spectrum of industries have slashed expectations for the coming quarter and beyond.
Top and Flop ETFs Last Week
by Sanghamitra Saha
These ETFs gained/lost the most amid the market blood bath last week.
Should Invesco Defensive Equity ETF (DEF) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for DEF
Coronavirus Triggers Market Bloodbath: 7 Hot Inverse ETF Areas
by Sanghamitra Saha
A rise in coronavirus cases outside China has intensified the scare for global markets. These inverse ETFs posted solid gains.
COVID-19 Spreads Worldwide, Pre-Markets Plunge
by Mark Vickery
Major stock market futures are down precipitously at this hour in today's pre-market, as new information related to the COVID-19 coronavirus exacerbates the perceived risk to human life and economic growth.
Update on COVID-19 & "The Next Recession"
by Mark Vickery
There are no reported new countries where the Wuhan coronavirus -- COVID-19 -- appears to have spread as of today, though the death toll as well as the number of confirmed cases continues northward.
Solar & Large-Cap Growth: 2 ETFs to Watch on Outsized Volume
by Sanghamitra Saha
TAN and SPYG saw massive trading volumes in yesterday's trading session.
Big Gains in Housing Starts, Building Permits, PPI
by Mark Vickery
January Housing Starts, Building Permits and Producer Price Index all blew away estimates this morning.
Coronavirus to Hurt Apple Earnings: Time to Buy These ETFs?
by Sanghamitra Saha
Production delays and lower demand caused by coronavirus are likely to affect Apple???s earnings results. Buy the likely dip in Apple???s shares with these ETFs.
4 Best Leveraged ETFs of Last Week
by Sanghamitra Saha
Inside the top-performing leveraged ETFs of last week.
QQQ: Superstar ETF of the Decade; Here???s Why
by Neena Mishra
Here's what investors need to know about QQQ, one of the best performing ETF of the past decade.
Econ Data, Coronavirus Assessment Ahead of 3-Day Weekend
by Mark Vickery
With a three-day weekend ahead of us and few concrete answers regarding the COVID-19 coronavirus, it may be difficult for stocks to hold onto the slight positive sentiment.